All Stories

  1. Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
  2. Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD
  3. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis
  4. Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis
  5. Intravenous administration of Tat-NR2B9c peptide, a PSD95 inhibitor, attenuates reinstatement of cocaine-seeking behavior in rats
  6. Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces
  7. MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling
  8. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
  9. The NMDA Receptor Subunit (GluN1 and GluN2A) Modulation Following Different Conditions of Cocaine Abstinence in Rat Brain Structures
  10. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
  11. Endothelial cells response to neutrophil‐derived extracellular vesicles miRNAs in anti‐PR3 positive vasculitis
  12. miRNA Regulation of NK Cells Antiviral Response in Children With Severe and/or Recurrent Herpes Simplex Virus Infections
  13. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
  14. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
  15. Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices
  16. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  17. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma
  18. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
  19. Emerging role of non-coding RNAs in allergic disorders
  20. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs
  21. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  22. Association of Factor V Leiden With Subsequent Atherothrombotic Events
  23. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
  24. Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens
  25. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
  26. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
  27. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
  28. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
  29. Legends of Allergy/Immunology: Andrew Szczeklik
  30. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort
  31. The interaction of laser radiation with tissue in the aspect of generating the process of decellularization in the preparation of animal origin autologous tissue
  32. Subphenotypes of NSAID‐exacerbated respiratory disease identified by latent class analysis
  33. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration
  34. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis
  35. IL-17–high asthma with features of a psoriasis immunophenotype
  36. Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins
  37. Cocaine-induced Changes in the Expression of NMDA Receptor Subunits
  38. Subtypes of eosinophilic asthma with discrete gene pathway phenotypes
  39. A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience
  40. Stratification of asthma phenotypes by airway proteomic signatures
  41. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease
  42. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
  43. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
  44. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
  45. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
  46. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria
  47. Stabilization of Synthetic Materials with Silver Particles
  48. Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin
  49. Molecular profiling of regulatory T cells in pulmonary sarcoidosis
  50. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
  51. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper
  52. Facilitated expansion of Th17 cells in lupus nephritis patients
  53. Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort
  54. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers
  55. U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes
  56. Eicosanoids and eosinophilic inflammation of airways in stable COPD.
  57. Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
  58. Surface modification of metallic materials designed for a new generation of artificial heart valves
  59. Fibroblast-to-myofibroblast transition in bronchial asthma
  60. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome
  61. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
  62. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma
  63. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting
  64. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer
  65. miR-200b downregulates CFTR during hypoxia in human lung epithelial cells
  66. Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
  67. Biomimetics in thin film design: Niche-like wrinkles designed for i-cell progenitor cell differentiation
  68. Respiratory syncytial virus infection influences tight junction integrity
  69. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients
  70. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects
  71. Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort
  72. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort
  73. Connexin43 Controls the Myofibroblastic Differentiation of Bronchial Fibroblasts from Patients with Asthma
  74. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
  75. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
  76. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
  77. Cocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex
  78. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis
  79. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
  80. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
  81. Urinary prostanoids in preschool wheeze
  82. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies
  83. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
  84. Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology
  85. The genetic evidence for human origin of Jivaroan shrunken heads in collections from the Polish museums
  86. Effect of DHA/EPA supplementation on endothelial damage markers. The bioclaims study
  87. Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
  88. Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition
  89. Wrinkle-like structures in reconstructing stem cell niches
  90. Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab
  91. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease
  92. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease
  93. Nanostructural haemocompatible coatings for the internal side of artificial blood vessels
  94. Silver nanoparticles influence on the blood activation process and their release to blood plasma from synthetic polymer scaffold
  95. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
  96. Lesions in the wingless gene of the Apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings, coming from the isolated population in Pieniny (Poland)
  97. Prostaglandin E2in Induced Sputum Following Oralaspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity
  98. Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
  99. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane
  100. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease
  101. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma
  102. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier
  103. A lack of Wolbachia-specific DNA in samples from apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings
  104. Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
  105. The first U-BIOPRED sputum handprint of severe asthma
  106. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics
  107. Mortality in end‑stage renal disease: the importance of the genetic background
  108. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema
  109. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia
  110. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
  111. T-cell regulation during viral and nonviral asthma exacerbations
  112. Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis
  113. In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  114. Computer engineering in designing and fabrication of tissue analogue-type coating dedicated for the cardiovascular regeneration
  115. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells
  116. Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  117. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency
  118. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
  119. Unravelling adverse reactions to NSAIDs using systems biology
  120. Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts
  121. Lack of association ofALOX12andALOX15Bpolymorphisms with psoriasis despite altered urinary excretion of 12(S)-hydroxyeicosatetraenoic acid
  122. S65 Urinary Prostaglandins As Inflammatory Markers For Childhood Asthma Exacerbations
  123. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
  124. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
  125. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity
  126. Graphene based porous coatings with antibacterial and antithrombogenous function—Materials and design
  127. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland
  128. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children
  129. AB0029 Imbalance between Immunoregulatory and Effector TH17 Pathway in Active Sle
  130. THU0498 Increase of CXCR3-CCR4+CCR6+CCR10- Memory T Helper Cells (TH17-LIKE) in Patients with Granulomatosis and Polyangiitis (GPA)
  131. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  132. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection
  133. Carbon in airway macrophages from children with asthma
  134. Risk factors for arterial thrombosis in antiphospholipid syndrome
  135. Phagocytosis of fossil fuel particulates by macrophages in children with asthma
  136. Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells
  137. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs
  138. Grubość kompleksu błona wewnętrzna – błona środkowa tętnicy szyjnej koreluje z cechami zespołu metabolicznego u osób młodych z kliniczną diagnozą rodzinnej hipercholesterolemii
  139. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients
  140. Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
  141. Mutations of microsatellite autosomal loci in paternity investigations of the Southern Poland population
  142. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs
  143. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients
  144. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
  145. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4
  146. Transforming growth factor-β1‑induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients
  147. Exhaled eicosanoid profiles in children with atopic asthma and healthy controls
  148. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients
  149. Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more: Figure 1–
  150. Biographical memoir: Andrew Szczeklik 29 June 1938–3 February 2012
  151. CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome
  152. Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
  153. The unfinished history of aspirin hypersensitivity – in memory of Professor Andrew Szczeklik
  154. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome
  155. Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
  156. Nasal Inflammatory Mediators In Non-steroidal Anti-inflammatory Drugs (nsaids) Cross-intolerant Subjects After Lysine Nasal Challenge
  157. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
  158. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
  159. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
  160. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  161. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell–cell contacts
  162. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration
  163. 832 INTIMA-MEDIA THICKNESS CORRELATES WITH FEATURES OF METABOLIC SYNDROME IN YOUNG PERSONS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
  164. 592 MUTATION SPECTRUM IN THE LDL RECEPTOR GENE IN PATIENTS FROM THE SOUTH-EASTERN PART OF POLAND
  165. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype
  166. Functional cardio-biomaterials
  167. Coxibs strike back
  168. Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation
  169. Eoxins: A new inflammatory pathway in childhood asthma
  170. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery
  171. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects
  172. Glucocorticoid receptor isoforms in steroid‑dependent asthma
  173. MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION
  174. Elevated urinary leukotriene E4excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA
  175. Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease
  176. Assessment of hemocompatibility of materials with arterial blood flow by platelet functional tests
  177. Interaction of functionalFCER2promoter polymorphism and phenotype-associated haplotypes
  178. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome
  179. Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener’s granulomatosis
  180. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years
  181. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease
  182. Single-stranded conformation polymorphism (SSCP)-driven indirect sequencing in detection of short deletion
  183. Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα)
  184. FCER1Agene proximal promoter polymorphisms in Caucasians and East Asians
  185. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma
  186. Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome
  187. Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T
  188. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma
  189. FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes
  190. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity
  191. The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland
  192. Molecular diagnostics of α1-antitrypsin deficiency
  193. Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients
  194. Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels
  195. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin
  196. FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites
  197. GENETIC POLYMORPHISMS OF THE NOVEL FCER1A GENE REGION: RELATION TO TOTAL SERUM IgE LEVELS
  198. Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening
  199. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease
  200. Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects
  201. Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management
  202. NOVEL EXON 2A OF THE HIGH-AFFINITY RECEPTOR FOR THE IgE α-CHAIN GENE (FCER1A) AND AUTOIMMUNITY IN PATIENTS WITH ASTHMA OR URTICARIA
  203. Towards a Multidisciplinary and Integrated Strategy in the Assessment of Adverse Health Effects Related to Air Pollution: The Case Study of Cracow (Poland) and Asthma
  204. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria
  205. The α-chain of high-affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels
  206. Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: The case study of Cracow (Poland) and asthma
  207. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies
  208. The broken balance in aspirin hypersensitivity
  209. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant
  210. Rhinovirus Infection in Lower Airways of Asthmatic Patients
  211. Reactive Oxygen Species Metabolism and Allergy
  212. Anti-thrombotic action of clopidogrel and PlA1/A2polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin
  213. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism
  214. Aspirin resistance
  215. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma
  216. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib
  217. The dopamine D4 receptor VNTR in Polish schizophrenia patients
  218. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
  219. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
  220. Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
  221. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression
  222. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
  223. Aspirin intolerance and the cyclooxygenase???leukotriene pathways
  224. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A "European Community Alport Syndrome Concerted Action" Study
  225. Aspirin and thrombinogenesis
  226. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma
  227. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
  228. 3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease
  229. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist
  230. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease
  231. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex
  232. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors
  233. Montelukast for persistent asthma
  234. Serum interleukin-5 in aspirin-induced asthma
  235. Leukotriene C4 synthase polymorphism and aspirin-induced asthma
  236. Aspirin-induced rhinitis and asthma
  237. Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia
  238. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma
  239. Genetics of aspirin induced asthma
  240. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa
  241. Enhanced Expression of the Leukotriene C4Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma
  242. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
  243. X-linked Alport Syndrome
  244. Frequency data on the loci vWA, FES/FPS, F13A01, TH01, TPOX and CSF1P0 in a population from South Poland
  245. Genetic Mechanisms in Aspirin-induced Asthma
  246. Molecular Studies in Osteogenesis Imperfecta (OI)
  247. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma
  248. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation
  249. Data on the loci LDLR, GYPA, HBGG, D7S8 and GC in a South Polish population
  250. Role of leukotrienes in aspirin-induced asthma
  251. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
  252. D1S80 VNTR locus genotypes in population of South Poland; meta-analysis pointer to genetic disequilibrium of human populations
  253. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  254. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel
  255. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p
  256. Limnology Of Missouri Reservoirs: An Analysis of Regional Patterns
  257. Alport syndrome: a genetic study of 31 families
  258. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene
  259. 165 MOLECULAR ANALYSIS OF PKU HAPLOTYPES IN THE POPULATION OF SOUTHERN POLAND
  260. 166 TIME-PLACE CLUSTERS ANALYSIS FOR SELECTED CONGENITAL MALFORMATION IN SOUTHERN POLAND
  261. Hypersensitivity to Aspirin and other NSAIDs